OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
NPHC
Nutra Pharma Corp.
Nutra Pharma Corp.
1537 NW 65th Avenue
Plantation, FL 33313
6400 Park of Commerce Blvd.
Suite 1B
Boca Raton, FL 33487
Rik J. Deitsch has been the President, Chief Executive Officer and a Director of the Company since November 7, 2002. From February 1998 through November 2002, Mr. Deitsch served as the President of NDA Consulting Inc., a biotechnology research group that provided consulting services to the pharmaceutical industry. NDA Consulting specialized in the research of peptides derived from Cone Snail venom, Cobra venom and Gila Monster venom. Mr. Deitsch holds both a B.S. in Chemistry and an M.S. in Biochemistry from Florida Atlantic University and has conducted clinical and laboratory research in collaboration with scientists at Duke University Medical Center and the Cleveland Clinic. Mr. Deitsch has served as an adjunct professor and taught several courses for Florida Atlantic University's College of Business and Continuing Education Department. He is the author of two books: Are You AgeWise - A Guide to Healthy Aging, and; Invisible Killers - the Truth Behind Environmental Genocide.
None
730 Third Ave
New York, NY 10017
International Square
1825 Eye Street N.W.
DC 20006
Nutra Pharma Corporation has ethical drugs in clinical development for the treatment of Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain. Our MS drug has received Orphan Designation from the FDA for the treatment of juvenile MS. Additionally, the Company markets drug products for sale for the treatment of pain under the brands Nyloxin®, Luxury Feet™, Equine Pain-Away™ and Pet Pain-Away™. The Company is also working on nerve agent countermeasures against organophosphate chemicals. Lastly, the company produces homeopathic drugs and dietary supplements for several private label customers, including Avini Health.
Since May 13, 2004, we have leased office space at 1537 NW 65th Avenue, Plantation, Florida for three consecutive two-year terms. The 5,500 square foot facilities include a reception area, conference room and five offices, a warehouse and a laboratory. In January of 202, we signed an updated lease with extended terms through January 1, 2026. The lease calls for current monthly payments of approximately $7,600, which includes base rent, common area expenses, real estate taxes and insurance. As of June 1, 2020 we have moved all of our operations into the Plantation facility. This facility has been registered with the FDA. As of September 15, 2023 we moved our manufacturing operations to 6400 Park of Commerce Blvd, Suite 1B, Boca Raton, Florida 33487. We share the facility with Avini Health. The 18,504 square foot facilities include a reception area, conference room, break room, six restrooms, 12 offices, a warehouse and four production rooms. The lease on the Boca Raton facility runs through September of 2030.
